e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased vascular endothelial growth factor in acute eosinophilic pneumonia
Nishigaki Y., Fujiuchi S., Yamazaki Y., Matsumoto H., Takeda A., Fujita Y., Okamoto K., Fujikane T., Shimizu T., Kikuchi K.
Source:
Eur Respir J 2003; 21: 774-778
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nishigaki Y., Fujiuchi S., Yamazaki Y., Matsumoto H., Takeda A., Fujita Y., Okamoto K., Fujikane T., Shimizu T., Kikuchi K.. Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur Respir J 2003; 21: 774-778
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Epidermal growth factor in the lungs of infants developing chronic lung disease
Source: Eur Respir J 2001; 18: 796-800
Year: 2001
Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Source: Eur Respir J 2005; 25: 626-633
Year: 2005
Increased expression of tumor necrosis factor receptors by bronchoalveolar cells in cryptogenic organising pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 565s
Year: 2006
Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity
Source: Eur Respir J 2003; 21: 842-847
Year: 2003
Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006
Increased vascular endothelial growth factors in nasopharyngeal aspirates from children with acute RSV bronchiolitis
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002
Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001
Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 190-194
Year: 2001
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury
Source: Eur Respir J 2001; 18: 100-106
Year: 2001
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006
Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation
Source: Eur Respir J 2013; 41: 396-401
Year: 2013
Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis
Source: Eur Respir J 2003 Dec 01;22(6):895-899
Year: 2003
Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 962-968
Year: 2001
Cytokines in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 50S-59S
Year: 2001
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats
Source: Eur Respir J 2007; 30: 31-39
Year: 2007
Mast cell-derived tumour necrosis factor is essential for allergic airway disease
Source: Eur Respir J 2008; 31: 773-782
Year: 2008
Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS
Source: Eur Respir J 2002; 19: 776-779
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept